Intracranial hemorrhage complicating anticoagulant prophylactic therapy in three hospitalized COVID-19 patients

SARS-CoV2 has led to a global pandemic affecting almost 3 million people in almost over 3 months. Various clinical presentations have been reported so far and no definite therapy is established. Anticoagulation is recommended by several experts to address the potential prothrombotic complications fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghani, Muhammad Usman, Kumar, Mukesh, Ghani, Usman, Sonia, Fnu, Abbas, Syed Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307498/
https://www.ncbi.nlm.nih.gov/pubmed/32572835
http://dx.doi.org/10.1007/s13365-020-00869-6
Descripción
Sumario:SARS-CoV2 has led to a global pandemic affecting almost 3 million people in almost over 3 months. Various clinical presentations have been reported so far and no definite therapy is established. Anticoagulation is recommended by several experts to address the potential prothrombotic complications from COVID-19, but its safety and regimen need further clinical trials and safety and efficacy profile. Here, we present three cases of intracranial hemorrhage in three critically ill patients with COVID-19 and discuss their course in relation to various regimens of anticoagulation used.

Ejemplares similares